Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

AHA Late-Breaker: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results

AHA Late-Breaker: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results

FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research


AHA Late-Breaker: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results

FromACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

ratings:
Length:
10 minutes
Released:
Jan 10, 2023
Format:
Podcast episode

Description

A new study examined a very common clinical question of which loop diuretic or water pill is better in patients living with heart failure - torsemide or furosemide? Prior studies suggested that torsemide might be better than furosemide but they had never been compared head-to-head in a large clinical trial. The TRANSFORM-HF trial compared these 2 therapies against each other. In this interview, Robert J. Mentz MD and Laxmi Mehta MD, FACC discuss the primary findings of AHA Late-Breaker: TRANSFORM-HF – Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure. Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
Released:
Jan 10, 2023
Format:
Podcast episode

Titles in the series (100)

The American College of Cardiology offers select interviews and summaries of cardiology’s most interesting research areas from ACCEL’s renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.